Zobrazeno 1 - 10
of 618
pro vyhledávání: '"D. Ioannides"'
Autor:
T. Newman, L. Stroman, M. Hadjipavlou, W. Mulhem, D. Ioannides, K. Chan, C. Milliken, T. Pinczes, B. Namdarian, J. Rusere, D. Patel, N. Mehan, R. Popert, M. Hammadeh
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e2312- (2020)
Externí odkaz:
https://doaj.org/article/eaebeaffbead4e5da7704f74be9add9f
Autor:
Eleni D. Rompoti, Alexis D. Ioannides
Publikováno v:
Administrative Sciences, Vol 13, Iss 11, p 235 (2023)
The aim of this article is to investigate two external flexible forms of employment—the leasing of workers through Temporary Work Agencies (TWAs) and the contracted workers employed through Business Service Providers (contractors). Undoubtedly, the
Externí odkaz:
https://doaj.org/article/02a4014f47534a54ba9fdd88b82b000b
Autor:
M, Augustin, P G, Sator, R, von Kiedrowski, C, Conrad, D, Rigopoulos, M, Romanelli, P-D, Ghislain, T, Torres, D, Ioannides, M, Aassi, B, Schulz, P, Jagiello
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36:1796-1804
Randomized controlled trials of secukinumab have shown sustained efficacy and a favourable safety profile in multiple manifestations of psoriatic disease.To assess the long-term, real-world retention, effectiveness and safety of secukinumab in routin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 37
Autor:
L. Borradori, N. Van Beek, C. Feliciani, B. Tedbirt, E. Antiga, R. Bergman, B. C. Böckle, M. Caproni, F. Caux, N.S. Chandran, G. Cianchini, M. Daneshpazhooh, D. De, D. Didona, G. M. Di Zenzo, M. Dmochowski, K. Drenovska, J. Ehrchen, M. Goebeler, R. Groves, C. Günther, B. Horvath, M. Hertl, S. Hofmann, D. Ioannides, B. Itzlinger‐Monshi, J. Jedličková, C. Kowalewski, K. Kridin, Y. L. Lim, B. Marinovic, A. V. Marzano, J.‐M. Mascaro, J.M. Meijer, D. Murrell, K. Patsatsi, C. Pincelli, C. Prost, K. Rappersberger, M. Sárdy, J. Setterfield, M. Shahid, E. Sprecher, K. Tasanen, S. Uzun, S. Vassileva, K. Vestergaard, A. Vorobyev, I. Vujic, G. Wang, K. Wozniak, S. Yayli, G. Zambruno, D. Zillikens, E. Schmidt, P. Joly
Publikováno v:
Borradori, L, Van Beek, N, Feliciani, C, Tedbirt, B, Antiga, E, Bergman, R, Böckle, B C, Caproni, M, Caux, F, Chandran, N S, Cianchini, G, Daneshpazhooh, M, De, D, Didona, D, Di Zenzo, G M, Dmochowski, M, Drenovska, K, Ehrchen, J, Goebeler, M, Groves, R, Günther, C, Horvath, B, Hertl, M, Hofmann, S, Ioannides, D, Itzlinger-Monshi, B, Jedličková, J, Kowalewski, C, Kridin, K, Lim, Y L, Marinovic, B, Marzano, A V, Mascaro, J M, Meijer, J M, Murrell, D, Patsatsi, K, Pincelli, C, Prost, C, Rappersberger, K, Sárdy, M, Setterfield, J, Shahid, M, Sprecher, E, Tasanen, K, Uzun, S, Vassileva, S, Vestergaard, K, Vorobyev, A, Vujic, I, Wang, G, Wozniak, K, Yayli, S, Zambruno, G, Zillikens, D, Schmidt, E & Joly, P 2022, ' Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) ', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 10, pp. 1689-1704 . https://doi.org/10.1111/jdv.18220
Journal of the European Academy of Dermatology and Venereology, 36(10), 1689-1704. Wiley
Journal of the European Academy of Dermatology and Venereology
Borradori, L; Van Beek, N; Feliciani, C; Tedbirt, B; Antiga, E; Bergman, R; Böckle, B C; Caproni, M; Caux, F; Chandran, N S; Cianchini, G; Daneshpazhooh, M; De, D; Didona, D; Di Zenzo, G M; Dmochowski, M; Drenovska, K; Ehrchen, J; Goebeler, M; Groves, R; ... (2022). Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV, 36(10), pp. 1689-1704. Wiley 10.1111/jdv.18220
Journal of the European Academy of Dermatology and Venereology, 36(10), 1689-1704. Wiley
Journal of the European Academy of Dermatology and Venereology
Borradori, L; Van Beek, N; Feliciani, C; Tedbirt, B; Antiga, E; Bergman, R; Böckle, B C; Caproni, M; Caux, F; Chandran, N S; Cianchini, G; Daneshpazhooh, M; De, D; Didona, D; Di Zenzo, G M; Dmochowski, M; Drenovska, K; Ehrchen, J; Goebeler, M; Groves, R; ... (2022). Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV, 36(10), pp. 1689-1704. Wiley 10.1111/jdv.18220
Background: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a40b727fc51bde64b209033f82ff775
https://pure.au.dk/portal/da/publications/updated-s2-k-guidelines-for-the-management-of-bullous-pemphigoid-initiated-by-the-european-academy-of-dermatology-and-venereology-eadv(17316991-e066-4972-a0d5-64664e9f1631).html
https://pure.au.dk/portal/da/publications/updated-s2-k-guidelines-for-the-management-of-bullous-pemphigoid-initiated-by-the-european-academy-of-dermatology-and-venereology-eadv(17316991-e066-4972-a0d5-64664e9f1631).html
Autor:
Aikaterini Patsatsi, A V Roussaki-Schulze, A. Drosos, D Ioannidou, G Anastasiadis, M. Papakonstantis, P. Aronis, M Papageorgiou, F Satra, Konstantinos Krasagakis, Z Anagnostopoulos, A. Protopapa, Ioannis D. Bassukas, V. Chasapi, D. Ioannides, Sophia Georgiou, Ch. Antoniou, N Antonakopoulos, Dimitrios Rigopoulos, E. Lazaridou, Ioanna Lefaki, O. Neofotistou, I Katsantonis
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35:1838-1848
BACKGROUND Apremilast is an oral phosphodiesterase-4 inhibitor indicated for patients with moderate-to-severe chronic plaque psoriasis and active psoriatic arthritis. OBJECTIVES To examine the effectiveness of apremilast on Dermatology Life Quality I
Autor:
E. Sotiriou, K. Bakirtzi, I. Papadimitriou, A. Tsentemeidou, N. Kougkas, A. Panagopoulou, D. Ioannides, E. Vakirlis
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV. 36(11)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.